Monday, March 25, 2013

Kyorin receives Approval for PENTASA ® Suppositories 1g, a drug for Ulcerative colitis

KYORIN Pharmaceutical Co., Ltd. has been marketing mesalazine drugs, PENTASA® Tablets
250mg, PENTASA ® Tablets 500mg and PENTASA ® Enema 1g in Japan while continuously engaging in the development for inflammatory bowel diseases (IBD), including Ulcerative colitis and Crohn’s disease. The development of PENTASA® Suppositories 1g has just been successfully completed as a new formulation, which is convenient to patients, that meets therapeutic needs for Ulcerative colitis

Enter your email address:

Delivered by FeedBurner